To examine the safety and potential benefits of bariatric surgery after breast cancer treatment on breast cancer recurrence.
Key Findings:
The median age at breast cancer diagnosis was 42 years, with 76.9% of patients being obese at diagnosis, highlighting the prevalence of obesity in this cohort.
The median time from breast cancer diagnosis to bariatric surgery was 3 years, indicating a potential delay in weight management.
Only one case of breast cancer recurrence was reported during a median follow-up of 11.7 years post-diagnosis, suggesting a favorable outcome for bariatric surgery in this population.
Interpretation:
Bariatric surgery appears to be safe for breast cancer survivors, with minimal recurrence observed in the studied cohort, indicating a need for further research to confirm these findings.
Limitations:
Small sample size of 13 patients limits generalizability and the ability to draw definitive conclusions.
Lack of a control group for comparison restricts the ability to assess the true impact of bariatric surgery on recurrence rates.
Conclusion:
Bariatric surgery may provide a safe option for weight management in breast cancer survivors, with low recurrence rates observed in this small cohort, but further research is necessary to validate these findings.
FOXC1 duplications were the second most common monogenic finding among genetically solved juvenile open-angle glaucoma cases in one registry, supporting the use of copy-number variant analysis in early-onset glaucoma testing.
